Susquehanna International Group
ICPT

Susquehanna International Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Susquehanna International Group’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-366,014
Closed -$6.79M – 13683
2023
Q3 		$6.79M Buy
366,014
+250,071
+216% +$2.83M ﹤0.01% 3070
2023
Q2 		$1.28M Sell
115,943
-104,852
-47% -$1.46M ﹤0.01% 6116
2023
Q1 		$2.97M Buy
220,795
+144,797
+191% +$2.51M ﹤0.01% 4352
2022
Q4 		$940K Sell
75,998
-209,738
-73% -$2.97M ﹤0.01% 6332
2022
Q3 		$3.99M Buy
285,736
+274,322
+2,403% +$4.42M ﹤0.01% 3523
2022
Q2 		$158K Sell
11,414
-58,668
-84% -$939K ﹤0.01% 10964
2022
Q1 		$1.14M Sell
70,082
-94,848
-58% -$1.49M ﹤0.01% 6795
2021
Q4 		$2.69M Sell
164,930
-76,219
-32% -$1.28M ﹤0.01% 4844
2021
Q3 		$3.58M Buy
241,149
+97,032
+67% +$1.55M ﹤0.01% 4586
2021
Q2 		$2.88M Buy
144,117
+33,607
+30% +$666K ﹤0.01% 5119
2021
Q1 		$2.55M Sell
110,510
-70,289
-39% -$1.96M ﹤0.01% 5335
2020
Q4 		$4.47M Buy
180,799
+67,853
+60% +$2.25M ﹤0.01% 3597
2020
Q3 		$4.68M Sell
112,946
-16,634
-13% -$764K ﹤0.01% 3137
2020
Q2 		$6.21M Buy
129,580
+62,068
+92% +$4.79M ﹤0.01% 2715
2020
Q1 		$4.25M Sell
67,512
-2,313
-3% -$208K ﹤0.01% 2790
2019
Q4 		$8.65M Sell
69,825
-67,664
-49% -$6.06M ﹤0.01% 2249
2019
Q3 		$9.12M Sell
137,489
-69,447
-34% -$4.66M ﹤0.01% 2075
2019
Q2 		$16.5M Buy
206,936
+178,266
+622% +$16M 0.01% 1439
2019
Q1 		$3.21M Sell
28,670
-25,118
-47% -$2.74M ﹤0.01% 3036
2018
Q4 		$5.42M Buy
+53,788
New +$5.58M ﹤0.01% 2190
2018
Q3 		– Sell
-26,151
Closed -$2.77M – 10492
2018
Q2 		$2.19M Sell
26,151
-116,067
-82% -$8.5M ﹤0.01% 3859
2018
Q1 		$8.75M Buy
142,218
+72,895
+105% +$4.39M ﹤0.01% 1914
2017
Q4 		$4.05M Sell
69,323
-301,368
-81% -$19M ﹤0.01% 2811
2017
Q3 		$21.5M Buy
370,691
+272,612
+278% +$29.4M 0.01% 1171
2017
Q2 		$11.9M Sell
98,079
-10,942
-10% -$1.27M 0.01% 1573
2017
Q1 		$12.3M Sell
109,021
-13,545
-11% -$1.58M 0.01% 1437
2016
Q4 		$13.3M Buy
122,566
+82,604
+207% +$9.84M 0.01% 1315
2016
Q3 		$6.58M Sell
39,962
-89,562
-69% -$14.1M ﹤0.01% 1925
2016
Q2 		$18.5M Buy
129,524
+8,194
+7% +$1.19M 0.01% 1020
2016
Q1 		$15.6M Sell
121,330
-57,581
-32% -$6.8M 0.01% 1169
2015
Q4 		$26.7M Sell
178,911
-38,726
-18% -$6.56M 0.01% 935
2015
Q3 		$36.1M Buy
217,637
+90,039
+71% +$19.8M 0.02% 817
2015
Q2 		$30.8M Sell
127,598
-116,591
-48% -$31M 0.01% 978
2015
Q1 		$68.9M Sell
244,189
-97,055
-28% -$21M 0.03% 498
2014
Q4 		$53.2M Buy
341,244
+24,732
+8% +$4.57M 0.02% 696
2014
Q3 		$74.9M Buy
316,512
+150,317
+90% +$38.3M 0.03% 529
2014
Q2 		$39.3M Buy
166,195
+105,900
+176% +$27.9M 0.02% 856
2014
Q1 		$19.9M Buy
60,295
+56,628
+1,544% +$19.1M 0.01% 1282
2013
Q4 		$250K Sell
3,667
-574
-14% -$33.2K ﹤0.01% 7886
2013
Q3 		$293K Buy
+4,241
New +$209K ﹤0.01% 7244

Susquehanna International Group's ICPT Position: Q4 2023 in Review

Susquehanna International Group sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 366,014 shares — an estimated $6.79M sold.

Susquehanna International Group first reported a position in ICPT in Q3 2013 and held it in 40 quarters. The position peaked at $74.9M in Q3 2014. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

  • Susquehanna International Group reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • Susquehanna International Group sold 366,014 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $6.79M.
  • Susquehanna International Group first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2013 and held it in 40 quarters.
  • Susquehanna International Group's Intercept Pharmaceuticals, Inc. position peaked at $74.9M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.